Studies with abanoquil (UK-52,046) a novel quinoline α1-adrnoceptor antagonist. II: Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects - SCHAFERS, R. F; ELLIOTT, H. L; MEREDITH, P. A; MILLER, S. H. K; REID, J. L (British journal of clinical pharmacology, 1991)
Keywords: Antiarythmic agents; Biological and medical sciences; Cardiovascular system; Medical sciences; Pharmacology. Drug treatments; Human; Heart rate; Alpha blocking agent; Intravenous administration; Activity concentration relation; α1-Adrenergic receptor; Hemodynamics; Normal; Pharmacokinetics; Antiarrhythmia agent